Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum sickness from iron-dextran administration.

L Bielory1

  • 1Division of Allergy and Immunology, UMDNJ-New Jersey Medical School, Newark.

Acta Haematologica
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical implications of mast cell involvement in allergic conjunctivitis.

Allergy·2017
Same author

Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis.

Current allergy and asthma reports·2014
Same author

Skin biopsies in the evaluation of atypical optic neuropathies.

Ocular immunology and inflammation·2012
Same author

Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis.

Allergy·2011
Same author

Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy.

The British journal of ophthalmology·2009
Same author

Diagnosis and management of adult onset Still's disease.

Annals of the rheumatic diseases·2005
Same journal

Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

Acta haematologica·2026
Same journal

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

Acta haematologica·2026
Same journal

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same journal

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Acta haematologica·2026
Same journal

Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

Acta haematologica·2026
Same journal

COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.

Acta haematologica·2026
See all related articles

Hypersensitivity vasculitis, an immune reaction to external triggers, can manifest as serum sickness syndrome. This case highlights cutaneous vasculitis following an intravenous iron-dextran infusion.

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Hypersensitivity vasculitis is an immune-mediated inflammatory condition.
  • It is often triggered by exogenous agents, including medications and infections.
  • Cutaneous vasculitis specifically affects the skin's blood vessels.

Observation:

  • A patient developed serum sickness syndrome.
  • The syndrome presented with characteristic cutaneous vasculitis.
  • This reaction occurred subsequent to receiving an intravenous iron-dextran infusion.

Findings:

  • Intravenous iron-dextran can act as an exogenous trigger for hypersensitivity vasculitis.
  • The case illustrates a direct link between iron-dextran administration and the development of serum sickness syndrome with cutaneous manifestations.

Related Experiment Videos

  • This suggests a potential immunogenic property of iron-dextran preparations.

    • Implications:

    • Clinicians should consider iron-dextran as a potential cause of hypersensitivity vasculitis and serum sickness syndrome.
    • Awareness of this adverse drug reaction is crucial for patient safety and appropriate management.
    • Further investigation into the immunopathogenesis of iron-dextran-induced vasculitis may be warranted.